[
AbbVie ovarian cancer drug shows 62.7% response rate in trial
[og_img]
https://www.investing.com/news/company-news/abbvie-ovarian-cancer-drug-shows-627-response-rate-in-trial-93CH-4609046
Investing.com
AbbVie ovarian cancer drug shows 62.7% response rate in trial
Related articles




